Loading...
StocksRunner logo
 
 
Bausch Health Compan
7.12
-1.86%
 
BHC Bausch Health Companies
Last Price
Change
7.12
 
-1.86%
 
 
 

 
Sentiment
 
  Login to display
 
 

7.12

7.58

7.7

8.75

 
 
1m
3m
6m
1y
 

Summary

  Login to display Bausch Health Companies (BHC) recommendation from the last 90 days from financial news and social media.
 

Risk Analysis

Risk Analysis

 Earnings are forecast to decrease

Risk Analysis

 Enter oversold territory

 
 

Risk Level

 
StocksRunner
 

Bausch Health Companies (BHC) has Low Risk Level

Click here to check what is your level of risk

 

Analysts Opinion

Click on the category for more information
 
 

Earnings

×
 

Earnings

2.00
 

StocksRunner

 Below analyst estimate

StocksRunner

 Loss widens YoY

StocksRunner

 Earnings decline YoY

 
 

Rating

×
 

Rating

NA
 
 

Momentum

×
 

Momentum

2.60
 

StocksRunner

 Price value has negative momentum

StocksRunner

 Enter oversold territory

 

Activity

×
 

Activity

3.50
 
 

Future

×
 

Future

2.75
 

StocksRunner

 Earnings are forecast to decrease

 
 

Analysts Opinion

Analysts opinion is negative and it remained unchanged from the past 3 months

 

Street Consensus

Buy
Opinion
Trend
Score
Potential
Score
 
35%
NA
30%
50%
 
On Track
On Track
On Track
 

Street Opinion 

Street view is unimpressive and have negative views on the near-term outlook

 
Events Rating
 
Very Bullish
Bullish
Neutral
Bearish
Very Bearish
 
Positive vs Negative
 
35%
65%
Positive
Negative
8 out of 23
events present
15 out of 23
events present
 

 
Events Calendar
Click for more information
 
May
S
M
T
W
T
F
S
June
S
M
T
W
T
F
S
 
Highlights
Last
Modify
Closing
Price
%
Change

 
Weak Earnings
2 Month Ago
5.83
-1.02%
 
Weak Earnings
2 Month Ago
5.89
-20.41%
 
Top Headlines

bausch (bhc) down on tentative approval to xifaxan anda. shares of bausch health companies inc. bhc were down 8.69% on jun 6 after the fda granted tentative approval to norwich pharmaceuticals

Wed Jun 7, 2023

Activity
Momentum

what to do after bausch health stock plunged by nearly 9% again.

Wed Jun 7, 2023

Momentum

bausch health sheds 13% as norwich sues for final fda approval of xifaxan.

Tue Jun 6, 2023

Activity
Activity

why bausch health companies stock is tanking today. what happened shares of bausch health companies (nyse: bhc) were down by 11.3% on sky-high volume as of 10:56 a.m. et tuesday morning. the big loss came after the drugmaker announced that the

Tue Jun 6, 2023

Momentum

bausch (bhc) gains on court ruling for xifaxan against norwich. shares of bausch health companies inc. bhc gained 5.3% after it obtained a favorable ruling from the United States district court of delaware for one of its top drugs xifa

Thu May 18, 2023

Momentum

bausch health options traders: stock will remain below this level through july expiration. ) shares rose sharply on wednesday. the laval canada-based company announced the United States district court of delaware upheld the final judgment for xifaxan 550

Thu May 18, 2023

Activity

why shares of bausch health soared wednesday. what happened shares of bausch health (nyse: bhc) were up more than 27% late wednesday afternoon because the company announced it had received a favorable court ruling affecting one of its leading t

Wed May 17, 2023

Momentum

bausch health soars amid skinny label court decision vs norwich over xifaxan drug.

Wed May 17, 2023

Momentum

bausch health: ish on long-term prospects awaiting subsiding headwinds.

Wed May 10, 2023

Potential
Potential
Potential

bausch health: theres still uncertainty.

Tue May 9, 2023

Potential

bausch healths (bhc) q1 earnings & sales miss shares down. shares of bausch health companies inc. bhc were down 20.41% in response to first-quarter 2023 results.

Fri May 5, 2023

Earnings
Momentum

why bausch health stock is tumbling today.

Thu May 4, 2023

Momentum

rsi alert: bausch health companies (bhc) now oversold. legendary investor warren buffett advises to be fearful when others are greedy and be greedy when others are fearful. one way we can try to measure the level of fear in a given stock is

Thu May 4, 2023

Momentum

bausch health stock falls ~15% as q1 net loss widens amid revenue miss.

Thu May 4, 2023

Earnings
Momentum

bausch health (bhc) misses q1 earnings and revenue estimates. bausch health (bhc) came out with quarterly earnings of $0.52 per share missing the zacks consensus estimate of $0.75 per share. this compares to earnings of $0.72 per share

Thu May 4, 2023

Earnings

bausch health companies gaap eps of -$0.55 misses by $0.42 revenue of $1.94b misses by $10m.

Thu May 4, 2023

Earnings

earnings preview: bausch health (bhc) q1 earnings expected to decline. the market expects bausch health (bhc) to deliver a year-over-year decline in earnings on higher revenues when it reports results for the quarter ended march 2023.

Thu Apr 27, 2023

Earnings

 
 
 
StocksRunner

Get all the pieces of the puzzle on important data activity before the major news sources break the story and find out what happening right now and what could happen in the future

FIND US ON

StocksRunner on Twitter StocksRunner on YouTube StocksRunner on stocktwits StocksRunner Rss
 

Receive our daily BHC alerts

Enter your email to receive daily alerts

 
Home

Leading Gainers

Upgrades

Downgrades

Top Leaders

 
Categories

Ipo's

Dividend

Option Activity

Insiders Activity

Institutional Holdings

 
Tags

New Products

FDA Approvals

Agreements

Financial Reports

 
About Us

Log In

Sign Up

Contact Us

Terms of use

Privacy Policy

 
 

Disclaimer: The Score performance whether actual or indicated by historical tests of strategies, is no guarantee of future performance or success. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The Readiness Indicators, Sentiment Indicators and total score are calculated by the retroactive application of a model constructed on the basis of historical data and based on assumptions integral to the model which may or may not be testable and are subject to losses. Active trading is generally not appropriate for someone of limited resources, limited invesment or trading experience, or low-risk tolerance. Your capital may be at risk.

Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").

This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.

 
StocksRunner

StocksRunner

Get the pulse of the market

 
StocksRunner

BHC Bausch Health Companies

Last Price
7.12
Change
-1.86%
 

Summary

  Login to display Bausch Health Companies (BHC) recommendation from the last 90 days from financial news and social media.

 
 
7.12
7.58
7.7
8.75
 
 
1m
3m
6m
1y
 
Sentiment
 

  Login to display

Risk Analysis

Risk Analysis

 Earnings are forecast to decrease

Risk Analysis

 Enter oversold territory

 
 
 
 
Street Consensus
 
Buy
Opinion
Trend
Score
Potential
Score
 
NA
30%
50%
On Track
On Track
On Track
 
35%
65%
Positive
Negative
8 out of 23
events present
15 out of 23
events present
 

Street Opinion

Street view is unimpressive and have negative views on the near-term outlook

 
 
Analysts Opinion
Hover the category for more information
 
 

Earnings

×
 

Earnings

2.00
 

StocksRunner

 Below analyst estimate

StocksRunner

 Loss widens YoY

StocksRunner

 Earnings decline YoY

 
 

Rating

×
 

Rating

NA
 
 

Momentum

×
 

Momentum

2.60
 

StocksRunner

 Price value has negative momentum

StocksRunner

 Enter oversold territory

 

Activity

×
 

Activity

3.50
 
 

Future

×
 

Future

2.75
 

StocksRunner

 Earnings are forecast to decrease

 
 

Analysts Opinion

Analysts opinion is negative and it remained unchanged from the past 3 months

 
 
 
 
 
Events Rating
 
Very Bullish
Bullish
Neutral
Bearish
Very Bearish
 
 
Risk Level
 
StocksRunner
 

Bausch Health Companies (BHC) has Low Risk Level.  Click here to check what is your level of risk

 
 
 

Events Calendar

Hover for information

 
May
 
S
M
T
W
T
F
S
 
June
 
S
M
T
W
T
F
S
 
 
 
 
Highlights
Last
Modify
Closing
Price
%
Change

 
Weak Earnings
2 Month Ago
5.83
-1.02%
 
Weak Earnings
2 Month Ago
5.89
-20.41%
 
 
 
StocksRunner

Get all the pieces of the puzzle on important data activity before the major news sources break the story and find out what happening right now and what could happen in the future

FIND US ON

StocksRunner on Twitter StocksRunner on YouTube StocksRunner on stocktwits StocksRunner Rss

 

Receive our daily BHC Alerts

Enter your email to receive daily alerts

 
Home

Leading Gainers

Upgrades

Downgrades

Top Leaders

Categories

Ipo's

Dividend

Option Activity

Insiders Activity

Institutional Holdings

Tags

New Products

FDA Approvals

Agreements

Financial Reports

 
 

Disclaimer: The Score performance whether actual or indicated by historical tests of strategies, is no guarantee of future performance or success. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The Readiness Indicators, Sentiment Indicators and total score are calculated by the retroactive application of a model constructed on the basis of historical data and based on assumptions integral to the model which may or may not be testable and are subject to losses. Active trading is generally not appropriate for someone of limited resources, limited invesment or trading experience, or low-risk tolerance. Your capital may be at risk.

Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").

This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.

 
 
 
 
 

Top Headlines